Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrenkel Topping Regulatory News (FEN)

Share Price Information for Frenkel Topping (FEN)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £61.45m
FEN Live PriceLast checked at - London Stock Exchange

Intraday Frenkel Topping Share Chart

AGM Statement

18 May 2016 07:00

RNS Number : 5275Y
Frenkel Topping Group PLC
18 May 2016
 

 

Frenkel Topping Group plc

("Frenkel Topping" or "the Company")

 

AGM Statement

 

Frenkel Topping (AIM: FEN), a specialist independent financial advisor and asset manager focussed on asset protection for vulnerable clients, will hold its Annual General Meeting today at 10.00 a.m. at Addleshaw Goddard LLP, 100 Barbirolli Square, Manchester, M2 3AB. At the meeting Chairman David Southworth will make the following statement:

 

Following last September's acquisition of FC Fund Managers, which has been renamed Frenkel Topping Investment Management ("FTIM"), the Company has been busy preparing and implementing its new business strategy with the aim of targeting a larger addressable market with our best of breed investment management solutions.

 

With FCA permissions received in March, we are now able to act as a discretionary investment manager with full retail permissions and, as such, have recently commenced re-papering clients and migrating funds whereby FTIM becomes the appointed discretionary investment manager for Assets under Management ("AUM"). The key development here is that investment management is no longer wholly outsourced to third parties.

 

In addition, having negotiated improved terms with an existing third party platform provider and other service providers, clients will benefit from lower fees, while at the same time our earnings on AUM will grow. We are also in talks to negotiate further deals with other fund managers. This will have a two-pronged benefit of improved revenue retention and increased competitiveness in winning new business.

 

The new model and FCA approvals are expected to yield higher margins and accelerated growth in profitability from 2017 as we migrate funds and benefit from providing a wider product offering to a larger potential customer base. As announced on 14 March 2016, the Board's expectations are that in the financial year ending 31 December 2017, we are comfortably on track, given no unforeseen external influences, to double operating profitability from that reported for the financial year ended 31 December 2015.

 

We now have £674m AUM compared to £666m at the year-end, despite some negative impacts from market conditions. 

 

Furthermore, our growing regional presence is also bearing fruit with offices in London, Birmingham, Leeds Cardiff and Bristol. As a result, 20% of AUM is from outside of our Manchester base. We now have a total of 17 consultants (14 as at 31 December 2015).

 

As ever, our 12th Deputy Day held this month proved hugely successful and provided a useful opportunity for us to further strengthen key relationships, assist with understanding of industry regulation and legislation and to introduce FTIM to Court of Protection professional deputies.

 

The highly cash generative nature of our model ensures that our balance sheet remains strong with £4.9m of cash on the balance sheet as at 30 April 2016 and we are now extremely well placed to add significantly more AUM over the coming years. This will be reflected in the progressive dividend that the Company has committed to paying to all shareholders. The current year has started in accordance with market expectations with a highly committed and proactive management team in place.

 

After almost 12 years as Chairman, I have informed the Board of my intention to retire from the Board. I will continue to act as Chairman until a suitable replacement has been identified and appointed.

 

I would like to thank all shareholders for their continued support and look forward to updating the market with further developments in due course.

 

 

For further information:

 

Frenkel Topping Group plc

www.frenkeltopping.co.uk

Richard Fraser, Chief Executive Officer

Tel: 0161 886 8000

Julie Dean, Chief Financial Officer

 

 

 

finnCap Ltd

Tel: 020 7220 0500

Adrian Hargrave/James Thompson/Alex Price (Corporate Finance)

Tony Quirke (Corporate Broking)

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 or frenkeltopping@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Nick Rome

Mob: 07748 325 236

 

 

About Frenkel Topping: www.frenkeltopping.co.uk

Frenkel Topping provides specialist independent financial advice focussed on asset protection for clients. The specialist independent financial adviser has a market leading position providing advice and fund management services for personal injury trusts and clinical negligence awards and is well placed to provide services to a wider customer base.

 

The Company provides a range of wealth management services including bespoke investment portfolios, financial and tax planning. It is focused on increasing its assets under management by growing the number of fee earners who are qualified to provide benefits protection for a variety of needs as the Company adds to its personal injury and clinical negligence specialism.

 

It has a national presence with offices in Manchester, Birmingham, Bristol, Cardiff, London and Leeds and has relationships and infrastructure in place to further grow its reach and target markets.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMAKODNABKDFPD
Date   Source Headline
21st Jul 20117:00 amRNSHalf Yearly Report
1st Jul 20117:00 amRNSChange of Adviser
20th Jun 20112:20 pmRNSDirector/PDMR Shareholding
15th Jun 20115:12 pmRNSCapital Reorganisation
13th Jun 20114:00 pmRNSHolding(s) in Company
10th Jun 201112:57 pmRNSCapital Reorganisation Update
8th Jun 20118:18 amRNSHolding(s) in Company
10th May 201110:31 amRNSResult of AGM
10th May 20117:00 amRNSAGM Statement
4th Apr 201112:09 pmRNSHolding(s) in Company
29th Mar 201112:33 pmRNSNotice of AGM
28th Mar 20111:58 pmRNSDirector/PDMR Shareholding
28th Mar 201110:34 amRNSDirector/PDMR Shareholding
24th Mar 20111:52 pmRNSIssue of Options
24th Mar 20117:00 amRNSFinal Results
2nd Feb 20114:21 pmRNSHolding(s) in Company
1st Feb 20119:48 amRNSHolding(s) in Company
15th Dec 20104:07 pmRNSDirectorate Change
30th Sep 20109:42 amRNSTotal Voting Rights
28th Sep 20104:27 pmRNSDirector/PDMR Shareholding
21st Sep 20102:38 pmRNSDirector/PDMR Shareholding
13th Sep 20104:41 pmRNSDirector/PDMR Shareholding
1st Sep 20102:59 pmRNSDirector/PDMR Shareholding
1st Sep 20102:55 pmRNSExercise of Options
11th Aug 20102:27 pmRNSDirector/PDMR Shareholding
9th Aug 20109:51 amRNSHalf Yearly Report
15th Jun 201010:24 amRNSDirector/PDMR Shareholding
8th Jun 201010:20 amRNSDirector/PDMR Shareholding
26th Apr 20109:46 amRNSDirector/PDMR Shareholding
13th Apr 201010:10 amRNSDirector/PDMR Shareholding
31st Mar 20109:10 amRNSFinal Results
26th Nov 20092:41 pmRNSDirector/PDMR Shareholding
24th Nov 20099:12 amRNSDirector/PDMR Shareholding
12th Nov 20099:19 amRNSDirector/PDMR Shareholding
30th Sep 20097:00 amRNSTotal Voting Rights
11th Sep 20097:51 amRNSDirector/PDMR Shareholding - Replacement
10th Sep 20098:48 amRNSDirector/PDMR Shareholding
4th Sep 200912:21 pmRNSIssue of Equity
16th Jul 20099:17 amRNSHalf Yearly Report
25th Mar 200911:06 amRNSDirector/PDMR Shareholding
24th Mar 20099:58 amRNSPreliminary Results
3rd Nov 20083:11 pmRNSDirector/PDMR Shareholding
30th Sep 20082:16 pmRNSDirector/PDMR Shareholding
9th Sep 200811:45 amRNSDirector/PDMR Shareholding
21st Aug 200811:27 amRNSInterim Results
13th Jun 20083:22 pmRNSHolding(s) in Company
14th May 200810:11 amRNSDirectorate Change
24th Apr 20082:44 pmRNSDirector/PDMR Shareholding
27th Mar 20083:52 pmRNSDirector/PDMR Shareholding
27th Mar 200812:26 pmRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.